r - Sm ae ren pa ge a LS Sm eae me ee meme ane
KOS195 L, p. fof Z
Candela Family of Pulsed Dye Lasers Pigmented Lesion Handpiece Accessory 510k Summary
G CANDELA WL a
s 510(k) Summary
This 510(k) is to provide notification of substantial equivalence for the Candela Family of Pulsed
Dye Lasers Pigmented Lesion Handpiece Accessory is indicated for use with the Candela
Family of Pulse Dye Lasers for the Treatment of Benign Epidermal Pigmented Lesions.
Submitted by: Candela Corporation
‘ 530 Boston Post Road
Wayland, MA 01778-1886
Contact Person: Lorraine Calzetta
Date prepared: May 13, 2005
Classification: Class II (21 CFR § 878.4810 Laser Surgical Instrument for use
in General and Plastic Surgery and in Dermatology)
Common Name: Dermatology Laser, Candela Family of Pulse Dye Laser Systems
: Predicate Devices:
Candela Family of Pulsed Dye Lasers - K043251
MSQ Family of Laser/Light System Handpieces - K040200
Lumenis Light Sheer —- K001746
Description: .
The Candela Family of Pulsed Dye Laser Systems are 585, 595nm flash-lamp excited pulse dye
medical lasers, indicated for the following uses:
The laser output energy is delivered via an optical fiber to a handpiece, which produces circular
beams or elliptical beams on the skin.. The Pigmented Lesion Handpiece Accessory attaches to
the standard handpiece and replaces the standard distance gauge for the treatment of benign
epidermal pigmented lesions
The Candela Family of Pulsed Dye Laser Systems is equipped with safety interlock systems to
protect patients and operators. Users of the device make selections from an onboard control
panel to regulate operation during treatment.
| The pigmented lesion handpiece accessory is designed for use with the Candela Pulsed Dye
| Laser handpiece, for the treatment of Benign Epidermal pigmented Lesions
Testing:
As a laser product, the Candela Family of Pulsed Dye Laser Systems conforms to the CDRH
! Laser Performance Standard (21 CFR 1040). And IEC 60601-1.Electrical Safety Standard.

. Candela Family of Pulsed Dye Laser Systems Pigmented Lesion Handpiece Accessory 510(k) Summary P
All materials contacting the patient conform to the requirements Of the FDA recognized
consensus standard ISO 10993-1.
Summary of Substantial Equivalence:
On the basis of similarities in key design aspects, intended uses and materials, Candela
Corporation believes that its Candela Family of Pulsed Dye Laser Systems Pigmented Lesion
Handpiece Accessory is substantially equivalent to the predicate devices.

7,
i & DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
a
Food and Drug Administration
9200 Corporate Boulevard
Rockville MD 20850
Ms. Lorraine Calzetta Patrovic JUL 1 3 2005
Manager, Regulatory Affairs
Candela Corporation / . ee
530 Boston Post Road
Wayland, Massachusetts 01778
Re: K051359
Trade/Device Name: Candela Family of Pulsed Dye Laser Systems: Pigmented Lesion
Handpiece Accessory
Regulation Number: 21 CFR 878.4810
Regulation Name: Laser surgical instrument for use in general and
plastic surgery and in dermatology
Regulatory Class: II
Product Code: GEX
Dated: May 20, 2005
Received: May 24, 2005
Dear Ms. Patrovic:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug,
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. The
general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration.
If your device is classified (see above) into either class I (Special Controls) or class II] (PMA), it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register. Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including, but not limited to: registration and listing (21
CFR Part 807); labeling (21 CFR Part 801), good manufacturing practice requirements as set
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Page 2 - Ms. Lorraine Calzetta Patrovic .
This letter will allow you to begin marketing your device as described in your Section 51 0(K)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device
to proceed to the market. So ete
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled,
"Misbranding by reference to premarket notification” (21CFR Part 807.97). You may obtain
other general information on your responsibilities under the Act from the Division of Small
Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or
(301) 443-6597 or at its Internet address http://www. fda.gov/cdrh/industry/support/index. htm.

Sincerely yours,

funn C. Provost, Ph.D.
Acting Director
Division of General, Restorative
and Neurological Devices
Office of Device Evaluation
Center for Devices and Radiological Health
Enclosure

Indications for Use

510(k) Number (if known): KOS 254

Device Name:

Candela Family of Pulsed Dye Laser Systems : Pigmented Lesion Handpiece

Accessory

Indications For Use:

e The Candela Family of Pulse Dye Laser Systems Pigmented Lesion Handpiece
Accessory is indicated for the Treatment of Benign Epidermal Pigmented
Lesions

Prescription Use _X AND/OR Over-The-Counter Use

(Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF

NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)
Page 1 of
“Vision OF Gen.”
40d Neurojogs 2b Restoragj
. Ogical Devices 1ve
- ood Nurabar KO S459 |

